Ask AI

Research Focus: Targeting the MCL-1 Pathway With CDK9 Inhibitors in AML

In this slideset and commentary I explore the novel approach of inhibiting CDK9 as a way of downregulating MCL-1 and thereby minimizing survival signals in AML cells.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Boston Biomedical